Chemist Body Seeks Transition Period, GST Input Adjustment After Tax Cut, Writes to CM

In a representation dated September 06, 2025, addressed to Delhi Chief Minister Rekha Gupta and Finance Minister, RDCA welcomed the GST reduction as a “positive step for patients” but flagged serious concerns for the trade. “The reduction of GST on medicines from 12% to 5% w.e.f. 22nd September 2025 is a welcome step for patients. However, it has created heavy accumulation of GST inputs and unsold higher-cost stock with pharmacies, causing immediate financial stress,” the RDCA wrote. Two Key Demands from Chemists To ensure uninterrupted supply of medicines during this transition, the association proposed two specific interventions: Transition Period: A 3-month window to allow depletion of old MRP stock purchased at higher tax. Input Adjustment Mechanism: A clear framework within 6 months for adjusting accumulated GST inputs to prevent losses for small and mid-sized pharmacies. “These timely relief measures will protect the pharma trade and ensure uninterrupted patient care in Delhi,” the letter emphasised.